Sanofi reviews

low bonus payments - even top 10% do not earn much above target bonus top performers not well rewarded poor forecasting - often significantly different than actual sales nationally and company rarely if ever adjusts the goal after they realize thier error weak managed care team somewhat bureaucratic new drug pipeline looks rather empty training is rather lax - easy to pass but some sales reps find their knowledge inadequate when they enter field sales

Senior management is very French - aka they pretty much hate the US even though it's the company's greatest source of revenue. While I was there, senior management frequently would say one thing and then do another (no, we are not re-aligning your territories, but then she would go and do it)